Skip to main content

Innoviva, Inc.

INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001080014

No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Innoviva, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of INVA: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2131221+9
Shares73.0M9.63M72.7M+9.39M (+14.8%)
Value$1.20B$157.9M$1.41B+$369.5M (+35.6%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Innoviva, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Sold out (15)

Institutions that held Innoviva, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of INVA in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
SummerHaven Investment Management, LLC59,853$981.6K
HSBC Holdings PLC57,832$936.3K
Balyasny Asset Management LLC51,751$848.7K
Jump Financial, LLC40,551$665.0K
ClearAlpha Technologies LP24,704$405.1K
Eqis Capital Management, Inc.11,742$192.6K
Profund Advisors LLC11,490$188.4K
Cornerstone Investment Partners, LLC10,334$169.5K
nVerses Capital, LLC3,800$62.3K
Innealta Capital, LLC2,016$33.1K
EdgeRock Capital LLC1,910$31.3K
Catalyst Funds Management Pty Ltd1,200$19.7K
RFP Financial Group LLC311$5.10K
Bell Investment Advisors, Inc44$722
Mather Group, LLC.8$122

Not filed for Q3 2024 yet (1)

Institutions that held Innoviva, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INVA in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.9,629,359$157.9M